Poster Abstracts - C518


Exome analysis reveals genomic markers associated with better efficacy of Nivolumab in lung cancer patients

Identification: Boidot, Romain

Nanobody-based depletion of protumoral tumor-associated macrophages as novel cancer therapy

Identification: Bolli, Evangelia

Quantitative Cell-Based Bioassays to Advance Immunotherapy Programs Targeting Immune Checkpoint Receptors

Identification: Brunet, Daniel

Aberrant MUC1 glycoforms modulate the interplay between tumor-associated macrophages and intestinal epithelial cells in IBD and CAC

Identification: Cascio, Sandra

A safe and highly efficient tumor-targeted type I interferon immunotherapydepends on the tumor microenvironment

Identification: Cauwels, Anje

Monitoring immune cells-mediated cytolysis through impedance technology allows kinetic analysis of reagent efficacy and combination synergy

Identification: Cerignoli, Fabio

Targeting T-cells to human cancer associated fibroblasts using an oncolytic virus expressing a FAP-specific T-cell engager

Identification: Champion, Brian

Imprime PGG modulates the functionality of immunosuppressive myeloid components of the tumor microenvironment and drives enhanced anti-tumor efficacy in combination with anti-PD1 antibody

Identification: Chan, Anissa

Long term time-course monitoring of NK cell-mediated ADCC using the Celigo Image Cytometer

Identification: Chan, Leo

Duration of treatment (DoT) of multiple myeloma regimens in patients (pts) with relapsed or refractory multiple myeloma (RRMM): findings in US clinical practice settings

Identification: Chen, Clara